A genetic variant in Rassf1a predicts outcome in mCRC patients treated with cetuximab plus chemotherapy: results from FIRE-3 and JACCRO 05 and 06 trials

作者:Sebio A; Stintzing S; Heinemann V; Sunakawa Y; Zhang W; Ichikawa W; Tsuji A; Takahashi T; Parek A; Yang D; Cao S; Ning Y; Stremitzer S; Matsusaka S; Okazaki S; Barzi A; Berger M D; Lenz H J
来源:The Pharmacogenomics Journal, 2018, 18(1): 43-48.
DOI:10.1038/tpj.2016.69